BioSpace News Archive

Crescent Capital Group LP, a leading alternative credit investment firm, announced that its European Specialty Lending strategy has provided financing to support the acquisition of AIO II by funds managed by Bencis Capital Partners and management.

Foresee Pharmaceuticals Co., Ltd., announced the topline results of FP-001 LMIS 25 mg phase 3 clinical trial, an open-label, single-arm study in subjects with Prostate Carcinoma.

Company values innovation and continuous improvement of patient care

Company acquires Colombian Based Cannabis Pharmaceutical Grade CBD Oils Producer and Distributor

Nutritional Products International (NPI), already known as Europe’s gateway to the U.S. market, is expanding its operations in 2019.

PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut Axis, announced two presentations at upcoming investor conferences.

Under Hildreth’s leadership, WellCare will administer the state’s Medicaid Prepaid Health Plans.

Product development & completion, customer success management, and rolling out both Hardware and Software in 2018 presented a great milestone for the company.

Amgen (NASDAQ: AMGN),Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier today announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in Heart Failure), the second Phase 3 clinical trial of omecamtiv mecarbil, a novel cardiac myosin activator, is open to enrollment.

The Ohio Mesothelioma Victims Center is appealing to a person in Ohio who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer or their family members to call them anytime at 800-714-0303 to make certain they understand how important it is to hire one of the nation’s most skilled attorneys to work on the victim’s compensation claim.